U.S., Aug. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07743788) titled 'Efficacy, Satisfaction, and Safety of the Mesolipo(R) Protocol for the Treatment of Localized Adiposity' on July 17.
Brief Summary: This randomized, split-body clinical trial aims to evaluate the efficacy, safety, and participant satisfaction of the Mesolipo(R) protocol for the treatment of localized adiposity. Participants will receive the Mesolipo(R) intervention on one side of the body and an active comparator on the contralateral side. Outcomes will be assessed through standardized clinical, photographic, ultrasonographic, and patient-reported measures over a 90-day follow-up period to determine treatment effectiveness and safety...